{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T04:39:30Z","timestamp":1772253570126,"version":"3.50.1"},"reference-count":38,"publisher":"Wiley","issue":"10","license":[{"start":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T00:00:00Z","timestamp":1158710400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acad Dermatol Venereol"],"published-print":{"date-parts":[[2006,11]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Objectives\u2002<\/jats:bold> To investigate the role of C282Y and H63D mutations, and hepatitis C virus (HCV) infection in the pathogenesis of porphyria cutanea tarda (PCT).<\/jats:p><jats:p><jats:bold>Design\u2002<\/jats:bold> Prospective case\u2010control study.<\/jats:p><jats:p><jats:bold>Setting\u2002<\/jats:bold> A large clinical and research institute for the study and treatment of cutaneous diseases in Barcelona, Spain.<\/jats:p><jats:p><jats:bold>Patients\u2002<\/jats:bold> Ninety\u2010nine consecutive patients with PCT and one hundred and twenty\u2010six control patients (76 healthy subjects and 50 patients chronically infected with HCV), were recruited.<\/jats:p><jats:p><jats:bold>Main outcome measures\u2002<\/jats:bold> The frequency of the C282Y and H63D mutations in patients with PCT vs. controls and the relationship of these mutations with HCV infection, and iron status, as judged by serum iron, liver iron and ferritin levels.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> C282Y mutation was significantly increased in PCT patients. This mutation was more frequent among non\u2010HCV\u2010infected patients. Increased ferritin levels and hepatic iron overload were also observed in PCT patients with heterozygous C282Y state. H63D mutation was only significantly increased among PCT patients with chronic hepatitis C infection. No significant iron overload was observed in patients with H63D mutation.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> This study confirms the high frequency of C282Y mutation in patients with PCT and its relationship with iron overload. The C282Y mutation has a relevant role in Spanish patients with PCT not associated with HCV chronic infection. On the other hand, the prevalence of the H63D mutation seems not to be increased in patients with PCT. The possibility of an association between HCV infection and H63D mutation in inducing PCT can be hypothesized.<\/jats:p>","DOI":"10.1111\/j.1468-3083.2006.01746.x","type":"journal-article","created":{"date-parts":[[2006,9,20]],"date-time":"2006-09-20T14:32:06Z","timestamp":1158762726000},"page":"1201-1206","source":"Crossref","is-referenced-by-count":15,"title":["The prevalence of HFE C282Y gene mutation is increased in Spanish patients with porphyria cutanea tarda without hepatitis C virus infection"],"prefix":"10.1111","volume":"20","author":[{"given":"A","family":"Toll","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R","family":"Celis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MD","family":"Ozalla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Bruguera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C","family":"Herrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MG","family":"Ercilla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,10,16]]},"reference":[{"key":"e_1_2_5_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197808102990603"},{"key":"e_1_2_5_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(93)90022-5"},{"key":"e_1_2_5_4_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00295407"},{"key":"e_1_2_5_5_2","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1182\/blood.V95.5.1565.005k42_1565_1571","article-title":"Hemochromatosis genes and other factors contributing to te pathogenesis of porphyria cutanea tarda","volume":"95","author":"Bulaj Z","year":"2000","journal-title":"Blood"},{"key":"e_1_2_5_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(62)90555-X"},{"key":"e_1_2_5_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1970.tb08003.x"},{"key":"e_1_2_5_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM196812122792402"},{"key":"e_1_2_5_9_2","first-page":"862","article-title":"Patterns of porphyrin excretion in Porphyria cutanea tarda under venesection treatment","volume":"12","author":"Enriquez de Salamanca R","year":"1980","journal-title":"Int J Biochem"},{"key":"e_1_2_5_10_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.0954-6820.1971.tb04337.x"},{"key":"e_1_2_5_11_2","doi-asserted-by":"publisher","DOI":"10.1159\/000247732"},{"key":"e_1_2_5_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(89)91506-0"},{"key":"e_1_2_5_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng0896-399"},{"key":"e_1_2_5_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(96)09436-6"},{"key":"e_1_2_5_15_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199705013361817"},{"key":"e_1_2_5_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270627"},{"key":"e_1_2_5_17_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80313-9"},{"key":"e_1_2_5_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.2000.03369.x"},{"key":"e_1_2_5_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510270128"},{"key":"e_1_2_5_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.510300320"},{"key":"e_1_2_5_21_2","first-page":"s1","article-title":"Diagnosis of porphyria\u2010recommended methods for peripheral laboratories","volume":"13","author":"Blake D","year":"1992","journal-title":"The Clinical Biochemist Reviews"},{"key":"e_1_2_5_22_2","first-page":"261","volume-title":"The Practical Approach Series","author":"Rossi E","year":"1986"},{"key":"e_1_2_5_23_2","first-page":"121","article-title":"Is hepatitis C virus infection a trigger or porphyria cutanea tarda?","volume":"128","author":"Herrero C","year":"1993","journal-title":"Lancet"},{"key":"e_1_2_5_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120105"},{"key":"e_1_2_5_25_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1747.2000.00148.x"},{"key":"e_1_2_5_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(98)80252-3"},{"key":"e_1_2_5_27_2","first-page":"828","article-title":"Mutation analysis of the HLA\u2010H gene in Italian hemochromatosis patients","volume":"60","author":"Carella M, D","year":"1997","journal-title":"Am J Hum Genet"},{"key":"e_1_2_5_28_2","unstructured":"BothwellTH CharltonRW MotulskyAG.Hemochromatosis. In: ScriverCR BeaudetAL SlyWS ValleD eds.The Metabolic and Molecular Basis of Disease. New York:McGraw\u2010Hill 1995:2237\u20132269."},{"key":"e_1_2_5_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.1993.tb15139.x"},{"key":"e_1_2_5_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840160603"},{"key":"e_1_2_5_31_2","doi-asserted-by":"publisher","DOI":"10.1159\/000068895"},{"key":"e_1_2_5_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1196-249"},{"key":"e_1_2_5_33_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.4.1472"},{"key":"e_1_2_5_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.96.4.1579"},{"key":"e_1_2_5_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.042701499"},{"key":"e_1_2_5_36_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.94.23.12384"},{"key":"e_1_2_5_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0014-5793(00)02173-6"},{"key":"e_1_2_5_38_2","doi-asserted-by":"publisher","DOI":"10.1038\/ng1196-251"},{"key":"e_1_2_5_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/75534"}],"container-title":["Journal of the European Academy of Dermatology and Venereology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-3083.2006.01746.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1468-3083.2006.01746.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,11]],"date-time":"2023-10-11T09:07:51Z","timestamp":1697015271000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-3083.2006.01746.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10,16]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2006,11]]}},"alternative-id":["10.1111\/j.1468-3083.2006.01746.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1468-3083.2006.01746.x","archive":["Portico"],"relation":{},"ISSN":["0926-9959","1468-3083"],"issn-type":[{"value":"0926-9959","type":"print"},{"value":"1468-3083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,10,16]]}}}